SCHEMBL23976261

SCHEMBL23976261

CCN(C)c1nc(-c2ccccn2)nc2sc(C)c(C)c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 2/20 0.44
▸ METAP1 P53582 2/20 0.44
▸ KDM4E B2RXH2 5/20 0.43
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ AGTR1 P30556 1/20 0.41
▸ SMN1; SMN2 Q16637 6/20 0.40
▸ HTT P42858 4/20 0.40
▸ LMNA P02545 3/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ ADORA2A P29274 1/20 0.39
▸ ADORA1 P30542 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ MITF O75030 1/20 0.38
▸ HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23975837 0.86 KDM4E (0.45) METAP2METAP1KDM4EMEN1KMT2A
SCHEMBL23991552 0.85 KDM4E (0.46) METAP2METAP1KDM4EMEN1KMT2A
SCHEMBL23975886 0.85 KDM4E (0.48) METAP2METAP1KDM4EMEN1KMT2A
SCHEMBL23976260 0.85 KDM4E (0.46) METAP2METAP1KDM4EMEN1KMT2A
SCHEMBL23975855 0.84 ALDH1A1 (0.44) METAP2METAP1KDM4EMEN1KMT2A
SCHEMBL23976691 0.81 KDM4E (0.41) METAP2METAP1KDM4EMEN1KMT2A
SCHEMBL23975881 0.81 LMNA (0.45) METAP2METAP1KDM4EMEN1KMT2A
SCHEMBL23976553 0.78 ALDH1A1 (0.43) METAP2METAP1KDM4EMEN1KMT2A
SCHEMBL25934447 0.78 KDM4E (0.40) METAP2METAP1KDM4ERAB9ASMN1; SMN2
SCHEMBL5120516 0.77 SMN1; SMN2 (0.54) METAP2METAP1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021222483-A1 METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-11-04 — — WO disclosed
Send feedback